LICN.NASDAQLichen China LTD

20-F: Lichen International Limited Reports Fiscal Year 2024 Results, Navigates Regulatory Changes and Strategic Acquisitions

Sentiment:

Annual Report


Lichen International Limited's 2024 annual report reveals a year of strategic shifts, including acquisitions, financial offerings, and adjustments to comply with evolving regulatory landscapes in both the U.S. and China.

Capital raiseOn May 2, 2024, the Company entered into securities purchase agreements with eight purchasers, each an unrelated third party to the Company (collectively, the Purchasers).Pursuant to the Securities Purchase Agreements, the Purchasers agreed to subscribe for and purchase, and the Company agreed to issue and sell to the Purchasers, an aggregate of 10,380,000 Class A ordinary shares, par value $0.00004 per share (the Class A Ordinary Shares), at a purchase price of $0.70 per share, and for an aggregate purchase price of $7,266,000 (the Offering).The Offering closed on May 13, 2024.The Company received gross proceeds of approximately $7,266,000 from the issuance and sale of the Class A Ordinary Shares, before deducting the estimated offering expenses payable by the Company.On December 26, 2024, the Company entered into a securities purchase agreement (the First Closing Purchase Agreement) with certain institutional investors named thereto (the Purchasers), pursuant to which the Company agreed to issue and sell, in a registered direct offering ( December 26 Registered Direct Offering): (i) 10,433,333 shares of Class A ordinary shares (the Class A Ordinary Shares) of the Company, par value $0.00004 per share (the First Closing Shares), at a purchase price of $0.14 per share; and (ii) pre-funded warrants to purchase up to 9,566,667 Class A Ordinary Shares (the First Closing Pre-Funded Warrants) at a purchase price of $0.139 per First Closing Pre-Funded Warrant.December 26 Registered Direct Offering closed on December 27, 2024.The Company received approximately $2.8 million in gross proceeds from December 26 Registered Direct Offering, before deducting placement agent fees and estimated offering expenses.On December 29, 2024, the Company entered into a securities purchase agreement (the Second Closing Purchase Agreement) with the same Purchasers, pursuant to which the Company agreed to issue and sell, in a registered direct offering ( December 29 Registered Direct Offering): (i) 13,200,000 Class A Ordinary Shares (the Second Closing Shares), at a purchase price of $0.125 per share; and (ii) pre-funded warrants to purchase up to 11,800,000 Class A Ordinary Shares (the Second Closing Pre-Funded Warrants) at a purchase price of $0.124 per Second Closing Pre-Funded Warrant.December 29 Registered Direct Offering closed on December 31, 2024.The Company received approximately $3.1 million in gross proceeds from December 29 Registered Direct Offering, before deducting placement agent fees and estimated offering expenses.On January 28, 2025, Lichen China Limited (the Company) entered into a securities purchase agreement (the Purchase Agreement) with certain institutional investors named thereto (the Purchasers), pursuant to which the Company agreed to issue and sell, in a registered direct offering (January 28 Registered Direct Offering): (i) 20,933,333 shares of Class A ordinary shares (the Class A Ordinary Shares) of the Company, par value $0.00004 per share (the Shares), at a purchase price of $0.08 per share; and (ii) pre-funded warrants to purchase up to 21,566,667 Class A Ordinary Shares (the Pre-Funded Warrants) at a purchase price of $0.079 per Pre-Funded Warrant.January 28 Registered Direct Offering closed on January 29, 2025.The Company received approximately $3.4 million in gross proceeds from January 28 Registered Direct Offering, before deducting placement agent fees and estimated offering expenses.
Worse than expectedThe company's net income decreased from $8.34 million in 2023 to a net loss of $6.12 million in 2024 due to increased operating expenses.

Summary

  • Lichen International Limited's 2024 annual report details the company's financial performance and strategic activities.
  • The company reported total revenue of approximately $41.48 million for the year ended December 31, 2024, an increase of 4.32% compared to the previous year.
  • Financial and taxation solution services contributed $34.29 million, representing 82.68% of total revenue, while education support services decreased to $2.90 million.
  • Software and maintenance services revenue remained relatively stable at $4.29 million.
  • The company incurred a net loss of $6.12 million for the year, compared to a net income of $8.34 million in the previous year, primarily due to increased operating expenses.
  • Lichen International completed several registered direct offerings throughout 2024, raising capital for working capital and general corporate purposes.
  • The company completed the acquisition of Bondly Enterprises Limited, aiming to integrate advanced technologies and AI capabilities.
  • Lichen International is navigating regulatory changes in the PRC, including those related to overseas listings and data security.
  • The company is also addressing compliance with the Holding Foreign Companies Accountable Act (HFCAA) in the U.S.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While revenue increased, the significant net loss and identified material weaknesses in internal controls raise concerns. The strategic acquisition and AI integration efforts offer potential positives, but the overall sentiment is cautiously negative.

Positives

  • Revenue increased by 4.32% to $41.48 million in 2024.
  • The company completed the acquisition of Bondly Enterprises Limited, expanding its AI capabilities.
  • The company is integrating the DeepSeek optimization framework into its Lichen Financial and Taxation AI Model.
  • The company has regained compliance with Nasdaq listing requirements after a reverse share split.

Negatives

  • The company incurred a net loss of $6.12 million in 2024, a significant shift from the $8.34 million net income in 2023.
  • Selling and marketing expenses increased significantly by $9.41 million, or 301.06%.
  • General and administrative expenses increased by $8.76 million, or 98.01%.
  • The company's disclosure controls and procedures were deemed ineffective due to a material weakness in internal control over financial reporting.

Risks

  • Changes in China's economic, political, or social conditions could adversely affect the business.
  • The company relies on dividends from PRC subsidiaries, and limitations on their ability to pay dividends could harm the business.
  • Fluctuations in exchange rates could negatively impact results of operations and the share price.
  • The company may be subject to PRC regulations regarding privacy, data security, and cybersecurity.
  • The company's Class A Ordinary Shares may be delisted under the Holding Foreign Companies Accountable Act (HFCAA) if the PCAOB is unable to inspect the company's auditors.
  • The company may face difficulties in enforcing contracts and legal rights in China.
  • The company may be subject to fines and other penalties if it fails to comply with PRC laws and regulations.
  • The company may not be able to successfully implement its strategies or achieve its business objectives.

Future Outlook

The company intends to use earnings for research and development, to develop new products, and to expand its production capacity, and does not expect to pay any cash dividends in the foreseeable future.

Industry Context

The financial and taxation solution services market in the PRC is rapidly evolving, highly fragmented and competitive. The company faces intense competition in its financial and taxation solution services in the geographical locations where it offers such services from many different smaller sized organizations that focus on providing similar services.

Comparison to Industry Standards

  • According to Frost & Sullivan, the top 10 Solution Service Specialists in the PRC only accounted for approximately 2.6% of the total market share in terms of revenue in 2019.
  • The financial and taxation solution services market in the PRC is rapidly evolving, highly fragmented and competitive.

Related Party Transactions

  • The company had transactions with Jinjiang Xingminqi Accounting Vocational Training School and Quanzhou City Lichen Accounting Vocational Training School, both controlled by the company's controlling shareholder, Ya Li.
  • These transactions involved the provision of marketing, operation, and technical support services, processing of academic education applications, and sales of teaching and learning materials.

Stakeholder Impact

  • Shareholders may be concerned about the net loss and the material weakness in internal controls.
  • Employees may be affected by the company's efforts to improve internal controls and adapt to changing regulations.
  • Customers may benefit from the company's expanded AI capabilities and improved service offerings.
  • Suppliers may be affected by changes in the company's procurement policies and relationships.

Next Steps

  • The company plans to continue to implement measures designed to improve its internal control over financial reporting.
  • The company is integrating the DeepSeek optimization framework into its Lichen Financial and Taxation AI Model, with completion scheduled by the end of Q2 2025.
  • The company will continue to monitor and comply with evolving regulatory requirements in the U.S. and China.

Key Dates

DateDescription
2004-04-14Lichen Zixun was established.
2013-12-20Legend Consulting BVI was incorporated.
2014-01-08Legend Consulting HK was formed.
2016-04-13Lichen International Limited (formerly Lichen China Limited) was incorporated.
2022-06-13Bondly HK was established.
2022-08-25Bondly XM was established.
2023-02-08Lichen International completed its initial public offering.
2023-12-28Lichen Singapore was established.
2024-05-02The Company entered into securities purchase agreements with eight purchasers.
2024-05-13The Offering closed.
2024-07-17The Company completed the payment of remaining balance of $5,000,000.
2024-07-12The Company entered into a Supplemental Share Purchase Agreement.
2024-07-17The Company completed the payment of remaining balance of $5,000,000.
2024-12-26The Company entered into a securities purchase agreement with certain institutional investors.
2024-12-27December 26 Registered Direct Offering closed.
2024-12-29The Company entered into a securities purchase agreement with the same Purchasers.
2024-12-31December 29 Registered Direct Offering closed.
2025-01-28Lichen China Limited entered into a securities purchase agreement with certain institutional investors.
2025-01-29January 28 Registered Direct Offering closed.
2025-02-07The Company entered into a Share Purchase Agreement.
2025-02-10The Board approved a one-for-two-hundred (1:200) Reverse Split of the Company's issued and unissued Class A and Class B ordinary shares.
2025-02-26The Company completed the payment of US$5,330,000.
2025-03-03Our Class A Ordinary Shares began trading on an adjusted basis, reflecting the Reverse Share Split.
2025-03-27The Company entered into an agreement to transfer 100% of the equity interests in the Xiamen City Legend Education Services Company Limited (Lichen Education).
2025-03-31The transaction was closed.
2025-04-02Ms. Lourdes Felix tendered her resignation as a director and the chair of the audit committee of the Company.
2025-04-02Mr. Kipton Cariaga tendered his resignation as a director and the chair of the nominating Committee of the Company.
2025-04-02Ms. Jingyu Lian has been appointed as the director, the chair of the audit committee, the chair of the nominating committee and a member of the compensation committee of the Company.

Keywords

financial and taxation solution services, Lichen International, annual report, HFCAA, China, PCAOB, acquisition, reverse share split, financial results, regulatory, AI

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.